Canopy Growth Stock Just Hit 52-Week Lows: Bargain or Beware?

Canopy Growth (TSX:WEED) stock announced earnings last week which included updated numbers related to BioSteel.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

Canopy Growth (TSX:WEED) fell to 52-week lows yet again this week, as Canopy Growth stock announced its most recent earnings. Shares have plunged 86% in the last year with no end in sight.

BioSteel mess

Canopy Growth stock announced further staff cuts in its latest earnings report, with specific attention placed on its BioSteel business. The company announced it would laying off several members of the BioSteel leadership team, and are currently in review of BioSteel to see if there are “legal remedies” open to the cannabis producer.

The remarks were made after Canopy Growth stock announced it would refile three of its past quarterly financial statements because of “misstatements” linked to BioSteel. Sales from the brand “should no longer be relied upon” the company said after going over its financial results for the financial year.

New details came out during the quarter and full-year results, providing investors with more reasons to apparently drop the stock.

More losses

Canopy Growth stock announced net loss in the fourth quarter came to $648 million, a $59 million increase on losses from the year before. Much of the loss, management stated, came from asset impairment and restructuring costs totaling around $164 million.

As for BioSteel, the corrected numbers saw a decrease of $10 million in net revenue for the 2022 year. The correction in numbers led to a $10 million decrease in net revenue for the year, and $14 million decrease in net revenue for the last nine months ending on Dec. 31, 2022.

Its other revenue sources from cannabis also came in lower. Net revenue for Canopy Growth stock was down 14% to $88 million, with its adjusted loss reaching $96 million. This was an improvement of $36 million from its negative adjusted earnings before interest, taxes, depreciation, and amortization last year.

Where Canopy Growth stock is headed next

It wasn’t all bad news, with Canopy Growth stock still seeing 101% increase in revenue for BioSteel. Plus, cost savings came in from the departure of 800 workers, or about 35% of its workforce back in February.

Still, cost savings from cuts isn’t what investors want to see. It also led to analysts cutting their price targets for the stock, with some pushing down its target price to under $1.

It’s certainly a long way down from the all-time highs reached by the cannabis stock before legalization in Canada. And, of course, investors want to know if it can turn things around.

As for now, that doesn’t look likely in at least the next year or so. Canopy Growth stock seems to take cuts as its main source of savings for now. Until it can reach a profit, investors are likely to continue seeing drops in share price for the foreseeable future. Drops so large, it may soon be kicked off the TSX.

Meanwhile, federal legalization of cannabis in the United States also doesn’t look likely. Not with an election coming up in the near future. So, if you’re hoping for a sudden climb in Canopy Growth stock, don’t hold your breath.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »